RING THERAPEUTICS Trademark

Trademark Overview

On Thursday, October 25, 2018, a trademark application was filed for RING THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the RING THERAPEUTICS trademark a serial number of 88169075. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 25, 2022. This trademark is owned by VL46, Inc.. The RING THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune/autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases
ring therapeutics

General Information

Serial Number88169075
Word MarkRING THERAPEUTICS
Filing DateThursday, October 25, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 25, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2019

Trademark Statements

Goods and Servicesencapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune/autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 8, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRING THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142
Party NameRING THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142
Party NameVL46, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, July 25, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 25, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 13, 2021SOU EXTENSION 5 GRANTED
Thursday, December 2, 2021SOU EXTENSION 5 FILED
Monday, December 13, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 2, 2021SOU TEAS EXTENSION RECEIVED
Saturday, June 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 17, 2021SOU EXTENSION 4 GRANTED
Thursday, June 17, 2021SOU EXTENSION 4 FILED
Thursday, June 17, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, December 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 14, 2020SOU EXTENSION 3 GRANTED
Monday, December 14, 2020SOU EXTENSION 3 FILED
Monday, December 14, 2020SOU TEAS EXTENSION RECEIVED
Friday, June 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 17, 2020SOU EXTENSION 2 GRANTED
Wednesday, June 17, 2020SOU EXTENSION 2 FILED
Wednesday, June 17, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, December 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 16, 2019SOU EXTENSION 1 GRANTED
Monday, December 16, 2019SOU EXTENSION 1 FILED
Monday, December 16, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, June 18, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 18, 2019ASSIGNED TO LIE
Monday, February 25, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 23, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 22, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 22, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 31, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 31, 2018NON-FINAL ACTION E-MAILED
Monday, December 31, 2018NON-FINAL ACTION WRITTEN
Monday, December 31, 2018ASSIGNED TO EXAMINER
Wednesday, November 28, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, November 8, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

therapeutics ring diseases disorders conditions cutaneous neurodegenerative hematologic neurological autoinflammatory inflammatory musculoskeletal